Poly(Ethylene Glycols) to Facilitate Celloidin Removal for Immunohistochemical Studies on Archival Human Brain and Temporal Bone Sections

Assessing Celloidin Dissolution in PEGs of Different Molecular Weights and Chemical Formulations

Uniform celloidin pellets were crafted from a recently solidified 12% celloidin block, the standard for embedding human TBs, using a 2-mm biopsy punch (#33-31, Miltex GmbH, Rietheim-Weilheim, Germany). Pellets were left to air-dry overnight, subsequently weighed with a digital analytical balance (AE 240S, Mettler Toledo, Greifensee, Switzerland) and submerged for 10 minutes in 50 ml of either pure diethylene glycol (PEG 106; Thermo Fisher Scientific Inc., Waltham, MA), PEG 200, PEG 300, PEG 400, or PEG 600 (TCI America, Portland, OR). Then, the pellets were rinsed in 1x phosphate-buffered saline (PBS) for 10 min, air-dried overnight, and reweighed. Using the before and after immersion weights (with five pellets tested for each PEG compound), we computed the percentage of dissolved celloidin. Using this experimental setup, we further determined celloidin dissolution in (1) diethylene glycol and PEG 200–600 of equimolar concentrations by diluting diethylene glycol (1:4.56, v/v), PEG 200 (1:2.03, v/v), PEG 300 (1:1, v/v), and PEG 400 (1:0.49, v/v) in distilled water, and thus normalizing their molar concentrations to the free hydroxyl groups per unit volume of PEG 600, (2) PEG 200 at the temperatures 4°C, 22°C, 30°C, 40°C, and 50°C, (3) for PEG 200 using celloidin pellets that were pre-soaked in either pure albumin (Mayer’s fixative, #R03203-70, Merck Millipore, St. Louis, MO), or varied albumin dilutions in PBS (ratios of 1:10, 1:100, 1:1000), and subsequently air-dried overnight before immersing them in PEG 200, and (4) for PEG dimethyl ether (PEG 240; #P224125G, TCI America), a PEG terminated with methoxy instead of hydroxyl groups.

NMR Spectroscopic Analysis of Celloidin Dissolution in PEG

A celloidin piece of approximately 5 × 10 × 30 mm was soaked in 80% ethanol overnight to clean them from cedarwood oil residues, a standard supplement introduced during celloidin block hardening, and air dried for 1 day. The prepared celloidin was immersed in PEG 200 at 20 wt% and stored at room temperature for 3 days to allow for complete dissolution of the celloidin. Proton nuclear magnetic resonance spectroscopy ( ¹ H-NMR), carbon nuclear magnetic resonance spectroscopy ( ¹³ C-NMR), and correlated nuclear magnetic resonance spectroscopy (COSY) spectra in deuterated acetone of PEG 200, celloidin, and celloidin dissolved in PEG 200 were acquired on a Bruker Avance III 400 NMR spectrometer (Bruker BioSpin Corp., Billerica, MA). One sample was used for each NMR measurement. Chemical shifts were reported relative to the respective solvent peak (C₃D₆O, δ = 2.05 ppm for ¹H-NMR and δ = 29.84 and δ = 206.26 for ¹³C-NMR and COSY).

Human Brain and TB Celloidin Sections

This study received approval from the Institutional Review Board at Massachusetts Eye and Ear (protocol no. 2020P000508). Celloidin-embedded human brain and TB sections from a total of seven tissue donors that were archived in the Otopathology Laboratory at Massachusetts Eye and Ear were used in this study. All specimens were initially embedded in celloidin (parlodion strips, Mallinckrodt Laboratory Chemicals, Phillipsburg, NJ) following established methods. ⁵ These sections, cut to a thickness of 20 µm, were archived in 80% ethyl alcohol at room temperature for 5 to 40 years prior to their utilization in this study.

Protein-Free, Heat-Facilitated Mounting of Celloidin Sections

The equipment and consumables required for this method are listed in Fig. 1A. The section, immersed in a petri dish with 80% ethanol, is floated onto ungummed cigarette paper (#M1689; OCB, Republic Technologies Int., Perpignan Cedex, France) using an angled glass rod (Fig. 1B). The cigarette paper is trimmed to a size slightly larger than the section to provide a thin border of celloidin around the tissue (Fig. 1C), placed face (section) down onto a SuperFrost Plus microscope slide (#12-550-15, Electron Microscopy Sciences, Hatfield, PA) (Fig. 1D), and then covered with a piece of bibulous paper (Fisherbrand, Fisher Scientific, Waltham, MA) soaked in distilled water (Fig. 1E) and a second cigarette paper (Fig. 1F), carefully avoiding any wrinkles and trapped air bubbles. The layered papers are then wetted with a few drops of distilled water before placing a 500-g lead weight with dimensions of 25.4 mm [W] × 50.8 mm [L] × 50.8 mm [H]) on top (Fig. 1G). After approximately 30 minutes, a few more drops of distilled water are added to the layered paper around the lead weight to prevent the sections beneath from drying out. After 1 hour, the weight and the papers are carefully removed one after the other (Fig. 1H to J). The mounted section is air-dried for approximately 10 minutes and covered with a sheet of polytetrafluoroethylene (PTFE) membrane (thickness 0.1 mm), which prevent detachment of adhesions of the histologic sections when storing multiple slides pressure in a mounting press (Fig. 1K). The slide is placed in a slide mounting press (#1465315, Technovit mounting press, Electron Microscopy Sciences) (Fig. 1L). The press is firmly tightened (Fig. 1M) and stored in a dry heat environment (e.g., paraffin oven) at 50°C (Fig. 1N). If multiple sections are mounted at a time, the slides covered with PTFE membrane can be stacked upon each other in the slide mounting press. The next morning, the mounting press is removed from the oven and cooled to room temperature before releasing its pressure (Fig. 1O), removing all slides from the press, and carefully peeling off the PTFE membrane from each slide (Fig. 1P). The mounted sections (Fig. 1Q) can be subsequently used for celloidin removal and immunohistochemistry (see next paragraphs), or stored at room temperature, for example, in a microscope slide box, for weeks to months before further use. This method is referred to as “protein-free mounting.”

OPEN IN VIEWER

Figure 1.

Step-by-step instructions for mounting archival celloidin sections for PEG 200-mediated celloidin removal. The detailed protocol, (A) to (Q), is given in the “Methods” section.

To compare the effectiveness of celloidin removal following protein-free mounting and the standard method that uses protein adhesive slide coating (“protein-mediated mounting”), some sections were mounted using gelatin-subbed glass slides smeared with albumin adhesive solution and dried for 1 hour at room temperature, as previously described. ⁸

Celloidin Removal From Celloidin Sections Using PEG 200

Mounted celloidin sections are immersed in a Coplin staining jar filled with PEG 200 (Fig. 2A) that is placed on a rocker shaker (Fig. 2B). Celloidin is completely dissolved after approximately 30 minutes in recently produced sections, and after approximately 60 min in archival (storage times above 15 years) sections. The slides are then transferred to a Coplin staining jar filled with distilled water (Fig. 2C). Residual, that is, incompletely removed, celloidin will eventually become visible as white (“foggy”) residue after approximately 3 minutes of immersion in distilled water (Fig. 2D). Slides with residual celloidin are transferred back to PEG 200 for another 15 to 30 min, depending on the amount of residual celloidin, before checking again for completeness of celloidin removal in distilled water (Fig. 2D). Changes between PEG 200 and distilled water can be repeated until celloidin is completely removed. PEG 200 can be recycled; that is, 50 ml of solution (approximately volume of one Coplin jar) can be used to dissolve the celloidin from approximately eight sections (2 × 1 inches) before the solution appears to saturate, as suggested by progressively longer times needed for complete celloidin removal.

OPEN IN VIEWER

Figure 2.

PEG 200-mediated celloidin removal from TB sections. (A) Mounted TB sections are immersed in a glass Coplin staining jar filled with PEG 200. (B) The jar is placed on a rocker shaker for 30 to 60 minutes. (C) To check for completeness of celloidin removal, the slides are then transferred to a Coplin staining jar filled with distilled water. (D) Incomplete celloidin removal will result in residual celloidin becoming eventually visible as white (“foggy”). No residual celloidin can be seen after complete celloidin removal.

For experiments comparing the effectiveness of celloidin removal between the method introduced here and the standard method, celloidin was dissolved from a few mounted sections using methanol saturated with sodium hydroxide, as described previously. ⁸

A detailed step-by-step protocol of the PEG 200-mediated celloidin removal is provided as Appendix. Possible solutions of issues that may be encountered are summarized in Table 1.

OPEN IN VIEWER

Table 1.

Troubleshooting Table With Issues That May Be Encountered With the PEG 200-Mediated Celloidin Removal and Possible Solutions.

Issue	Reason	Possible Solution
During air-drying (following step in Fig. 1J), sections start to lift off the slide.	Sections may be soaked with cedarwood oil.	Wash sections in 80% alcohol overnight.
	Sections may be cut with a dull knife, resulting in a ruffled surface.	Reduce air-drying time and cover sections immediately with PTFE membrane (continue with step in Fig. 1K) as soon as sections start to lift off.
Sections lift off slide during PEG immersion (step in Fig. 2B).	Insufficient pressure during storage in mounting press.	Apply firm pressure with the mounting press.
	Insufficient heat was maintained in the oven overnight.	Leave sections for longer in the oven.
	Sections were left for too long in PEG.	Shorter immersion time, use diluted PEG solution
Residual celloidin is visible in sections after PEG-mediated celloidin removal (step in Fig. 2C).	Time in PEG is not long enough, particularly when dealing with sections archived for more than 15 years.	Extend PEG immersion time on the rocker shaker.
	When utilizing recycled PEG, the solution might become “saturated.”	Use fresh PEG solution.

HE Staining

Celloidin sections were processed either by (1) HE staining free-floating without prior celloidin removal, then mounting and coverslipping with Permount (#SP15-500, Fisher Scientific, Pittsburgh, PA) on microscope slides (standard method), (2) mounting on microscope slides using protein-free mounting (see Fig. 1), followed by HE staining and coverslipping in Permount without prior celloidin removal, or (3) protein-free mounting followed by celloidin removal (see Figs. 1 and 2) prior to HE staining and coverslipping in Permount. To assess whether protein-free heat-facilitated section mounting and PEG 200-mediated celloidin removal methods introduce any tissue damage or other artifacts, we qualitatively compared the light-microscopic histomorphology of celloidin sections processed with these three approaches.

Immunohistochemistry

Celloidin sections were either mounted using the standard method (protein-mediated mounting) or the protein-free mounting method, followed by celloidin removal using sodium methoxide ⁸ or PEG 200 (present protocol). Sections from which celloidin had been removed were subsequently used for enzyme immunohistochemistry with 3,3ʹ-diaminobenzidine (DAB) and immunofluorescence labeling.

For DAB immunohistochemistry, sections were incubated with 5% normal horse serum (NHS) in PBS for 30 min. Next, a primary antibody raised in rabbit and directed against ADAM metallopeptidase with thrombospondin type 1 motif 18 (ADAMTS18; #NBP1-91651, Novus Biologicals, Centennial, CO) was applied overnight. The sections were then incubated with a biotinylated secondary antibody raised in goat and directed against rabbit IgG (#111-065-144, Jackson Immunoresearch, West Grove, PA) for 1 hour, followed by application of a horseradish peroxidase-based avidin-biotin (ABC) reagent (#PK-4000, Vector Laboratories, Newark, CA) for 1 hour. Then, the sections were incubated in 4% DAB/hydrogen peroxide in PBS for 5 minutes to develop the brown reaction product. Between all steps, the sections were washed in PBS for 5 min. Hematoxylin was used to counterstain cell nuclei. The slides were then dehydrated in an ascending ethanol series, cleared with Histoclear (#HS2001GLL, National Diagnostics, Atlanta, GA), mounted with Permount (#SP15-500, Fisher Scientific), and air-dried.

A negative control experiment was performed by immunolabeling human fetal otic capsule tissue using an anti-Adamts18 antibody with pre-absorbing the antibody overnight at room temperature with the control peptide (10:1; #NBP1-91651PEP, Novus Biologicals; Fig. A1).

For immunofluorescence labeling, sections were either incubated overnight with a primary antibody directed against osteoprotegerin (OPG; #ab73400, Abcam, Waltham, MA; dilution 1:100) and raised in rabbit, or with two primary antibodies that were directed against neurofilament 200 (NF200; #N4142, MilliporeSigma, Burlington, MA; dilution 1:500) and α-tubulin (#T5168, MilliporeSigma; dilution 1:100) and that were raised in rabbit and mouse, respectively. The primary antibodies were visualized by incubating sections for 1 hour with secondary antibodies conjugated with Alexa 488 (#A21206, Invitrogen/ThermoFisher Scientific, Carlsbad, CA; dilution 1:400) and Alexa 568 (#A10037, Invitrogen/ThermoFisher Scientific; dilution 1:400) respectively, both of which were raised in donkey, before coverslipping in Vectashield mounting medium with DAPI (#H-1200, Vector Laboratories, Burlingame, CA). All antibodies were diluted in 1% NHS in PBS. All incubation steps were performed at room temperature.

Image Acquisition

DAB-stained sections were analyzed using an Olympus BX51 microscope (Olympus, Tokyo, Japan) equipped with an Olympus DP70 digital camera (Olympus). Analysis of fluorescent-labeled sections was performed using a Leica TCS SP8 confocal microscope (Leica, Mannheim, Germany).

Statistics

Statistical analyses were performed using Prism for Apple Macintosh, version 9.5.1 (GraphPad Software, Inc., La Jolla, CA). To test whether means of several experimental groups are different, a one-way analysis of variance (ANOVA) with post-hoc multiple comparisons was used. To correct for multiple comparisons, Tukey’s test was used for data with normal distribution, and Dunn’s test was used for data with non-normal distribution. The significance level was set to p < 0.05.

Celloidin Dissolution With Low Molecular Weight PEG

PEGs are linear polymers of the monomer ethylene glycol and are categorized according to their average number of monomers (Fig. 3A), determining their molecular weight (MW) and chemical features. ¹³ We explored the celloidin dissolution rates for diethylene glycol (PEG 106; average MW = 106 g/mol), PEG 200 (MW = 200 g/mol), PEG 300 (MW = 300 g/mol), and PEG 400 (MW = 400 g/mol), and PEG 600 (MW = 600 g/mol), as well as for PEG dimethyl ether (PEG 240). Those, in contrast to higher MW PEG compounds (PEG ≥ 800), are in a liquid state at room temperature and thus, are, in principle, suited for a celloidin removal protocol at room temperature. Here, we determined the celloidin dissolution rates (kinetics) for diethylene glycol—PEG 600 by immersing standardized celloidin pellets (Fig. 3B) in neat solutions of these compounds and measuring the pellets’ dry weight loss after 10 minutes of immersion. We measured a significant weight loss—corresponding to high celloidin dissolution rates—for diethylene glycol, and PEG 200 to 400, while we did not observe a significant weight change for PEG 600 (Fig. 3C). Among the PEGs terminated with hydroxyl groups, the highest celloidin dissolution rate was determined for PEG 200, with decreasing dissolution rates for increasing PEG MW; except for the lowest-molecular-weight oligomer, diethylene glycol, which dissolved slightly (mean difference 8.7 percentage points, p = 0.03) less celloidin as compared with PEG 200 with more variable data (diethylene glycol < PEG 200 > PEG 300 > PEG 400 > PEG 600; Fig. 3C). PEG 240 terminated with methoxy instead of hydroxyl groups dissolved significantly more celloidin that PEG 200. To equalize the molar concentration of hydroxyl functionalities, that is, the quantity of reactive OH groups (Fig. 3A) per volume, which decreases with increasing MW of the PEG compound in neat solutions as used in the experiments above, we prepared solutions of each compound with a fixed molar concentration of hydroxyl groups (relative to neat PEG 600). After diluting diethylene glycol, PEG 200, PEG 300, and PEG 400 to match the molar concentration of hydroxyl groups in PEG 600, we found markedly reduced celloidin dissolution rates for all compounds (Fig. 3D). Nevertheless, a significant reduction in pellet weight was still observed for diethylene glycol, PEG 200, PEG 300, and PEG 400.

OPEN IN VIEWER

Figure 3.

Determining the relative and absolute celloidin solubility for PEGs. (A) General chemical structure of PEG with varying number (n) of repeating units of ethylene glycol. The polar hydroxyl groups are outlined in red. (B) Celloidin pellet used for determining the celloidin solubility in solutions of PEGs. (C) Celloidin solubility in PEGs of different molecular weight. (D) Celloidin solubility in PEGs of different molecular weight at equimolar concentrations of hydroxyl groups normalized to PEG 600. (E) Celloidin solubility in PEG 200 at different temperature levels. The upper graph shows the correlation between temperature und relative celloidin solubility. (F) Comparative NMR spectroscopic analysis of nitrocellulose before and after dissolution in PEG 200, with spectra displayed for PEG 200 (top left spectrum), celloidin (middle left spectrum), and celloidin dissolved in PEG 200 (bottom left spectrum). The persistence of key spectral features in the celloidin and celloidin in PEG 200 spectra (red dashed box) indicates that celloidin does not undergo detectable changes in its chemical structure when dissolved in PEG 200. Green dashed box, characteristic spectral region of PEG 200. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; n. s., not statistically significant; r, correlation coefficient. Solid line indicates linear regression line. In Fig. 3C to E, the y-axis applies to both the upper (dissolved celloidin) and lower (celloidin pellet weight) panel.

Celloidin Dissolution in PEG Exhibits Temperature-Dependent Kinetics

We tested the effect of different temperatures on the celloidin dissolution rates in PEG 200, the compound that demonstrated (one of) the highest celloidin dissolution rates, rendering it the preferred candidate for celloidin removal from tissue sections. Within the tested temperature range, that is, from 4°C to 50°C, we found a strong negative correlation between decreasing temperature and the amount of dissolved celloidin (r = −0.93, p < 0.0001; Fig. 3E), although increasing the temperature from 22°C (room temperature) to 30°C had no significant effect on the amount of dissolved celloidin. At 40°C, significantly more celloidin was dissolved in PEG 200, but exposing mounted sections to 40°C, in our experience, leads to their partial or complete detachment from the glass slides.

Celloidin dissolution in PEG did not result in changes in the molecular structure of the polymers

To explore the chemistry underlying celloidin dissolution in PEG 200, we investigated samples of celloidin, PEG 200, and the solution of celloidin in PEG 200, using NMR (Fig. 3F). In ¹H-NMR and ¹³C-NMR spectroscopic measurements, the peaks corresponding to PEG 200 and celloidin did not change substantially in all three samples, indicating that the dissolution was not mediated by molecular changes to the celloidin polymer. In addition, COSY analysis, which indicates protons that are in close proximity of each other via chemical binding, of the dissolved mixture did not indicate any coupling between hydrogens of PEG 200 and as would appear at potential sites of chemical binding. This finding further argues against the formation of intermolecular species between PEG 200 and celloidin.

Celloidin-Protein Interactions Abolish the Dissolution of Celloidin in PEGs

In pilot experiments, we observed that coating microscope slides with the protein adhesives gelatin and albumin, as is part of the protein-mediated mounting method,^5,8 prolonged complete celloidin removal from approximately 1 hour to several (3–4) weeks. To systematically investigate the chemical interactions between celloidin, proteins, and PEG and to identify avenues to optimize the celloidin removal protocol for tissue sections, we soaked celloidin pellets in albumin before immersion in PEG 200, which completely abolished celloidin dissolution (no significant pellet weight change) within the 10-min immersion period for all tested albumin concentrations (1:1, 1:10, 1:100, 1:1000; Fig. 4A). We further assessed the kinetics of celloidin removal more qualitatively on toluidine blue-stained TB sections after protein-mediated mounting^5,8 and protein-free mounting (see material and methods section, Fig. 1) and immersion in PEG 200 for 60 min. Light microscopic and confocal (tissue and celloidin autofluorescence; excitation filter: 560/40 nm; emission filter: 610/75 nm) analyses demonstrated complete removal of the lightly toluidine blue-stained celloidin matrix from sections after protein-free mounting (Fig. 4B and B’) and an incomplete celloidin removal with abundant, patchy residual celloidin on sections after protein-mediated mounting (Fig. 4C and C’).

OPEN IN VIEWER

Figure 4.

Interaction of PEG 200-mediated celloidin removal with albumin. (A) Solubility in PEG 200 of pellets that were pre-soaked in albumin. ****, p < 0.0001; n. s., not statistically significant. (B–C’) Qualitative assessment of PEG 200-mediated celloidin removal from TB sections after protein-free (B–B’) and protein-mediated (C–C’) mounting. In each row, the first three images show PEG 200-mediated celloidin removal of a toluidine blue stained-celloidin TB section over 60 min at intervals of 20 min. The last two images (B,’ C’) show laser scanning-based tissue and celloidin autofluorescence at 594 nm after 60 min of PEG 200-mediated celloidin removal of the respective TB section (dashed square indicates area shown in higher magnification on the right). Note the residual autofluorescent celloidin in the middle ear (ME) and the external auditory canal (EAC) as well as in the human TB tissue. TM, tympanic membrane. Scale bars: B/C, B’/C’ (left panel) 500 μm; B’/C’ (right panel) 100 μm.

Protein-free mounting and PEG-based celloidin removal preserve tissue morphology and enhance tissue antigenicity of archival celloidin sections

We mounted celloidin sections either with the standard method using protein adhesives (protein-mediated mounting) or with our heat-facilitated protein adhesive-free mounting technique (protein-free mounting), followed by celloidin removal using either sodium methoxide or PEG 200 to compare the effects of the different mounting and celloidin removal methods in subsequent histochemical and immunohistochemical applications.

HE-stained TB sections processed with the novel protein-free mounting technique followed by PEG 200-mediated celloidin removal demonstrated excellent morphological preservation with only very minor artefactual damage (Fig. 5). Since HE staining was performed on mounted sections instead of free-floating (Fig. 5A and A’), the staining intensity was overall weaker (Fig. 5B to C’), necessitating adjustments in staining times.

OPEN IN VIEWER

Figure 5.

Histomorphology (HE staining) of TB sections following (A–A’) free-floating HE staining, without prior section mounting or celloidin removal, and coverslipping in Permount (reference method), (B–C’) protein-free mounting without (B–B’) and with (C–C’) subsequent PEG 200-mediated celloidin removal (protocols in Figs. 1 and 2). Note the different staining intensities due to free-floating (A–A’) vs. mounted (B–C’) HE staining. Arrowheads, artefactual damage; CN VIII, cranial nerve eight (vestibulocochlear nerve). Scale bars: A 1 mm; A’ 200 µm.

After protein-mediated mounting of celloidin sections, neither sodium methoxide (five rinses) nor PEG 200 (2 hours immersion) sufficiently removed the celloidin matrix. This resulted in nonspecific staining of residual celloidin that obscured most of the sections when applying enzyme immunohistochemistry with DAB for visualizing an anti-Adamts18 primary antibody (Fig. 6A and B). In contrast, after protein-free mounting, both sodium methoxide and PEG 200 achieved virtually complete removal of the celloidin matrix, enabling specific and strong immunolabeling of ADAMTS18 in the spiral ligament and the encapsulating otic capsule, as demonstrated in TB sections from a human fetus at 19 weeks gestational age (Fig. 6C and D). Similarly, when applying immunofluorescence labeling for OPG, NF200, and α-tubulin on sections after protein-mediated mounting and treatment with sodium methoxide, extensive celloidin residues caused strong unspecific autofluorescence signals and made interpretation of any specific immunolabeling impossible (Fig. 6E and G). In contrast, TB sections processed using protein-free mounting and treated with PEG 200 demonstrated specific, background-free fluorescence labeling of OPG in cells in the spiral limbus, supporting cells on the basilar membrane, and osteocytes in the otic capsule (Fig. 6F). Moreover, brain sections processed using the same protocol demonstrated specific, background-free fluorescence labeling of NF200 and α-tubulin (Fig. 6H). The immunostaining patterns for ADAMTS18 and OPG in human TB sections, achieved using the new protocol described here, will be described and discussed in separate publications.

OPEN IN VIEWER

Figure 6.

Enzyme immunohistochemistry with DAB and immunofluorescence labeling of TB and brain sections following celloidin removal using either methoxide or PEG 200 and either protein-mediated or protein-free mounting. (A–D) DAB immunolabeling for ADAM Metallopeptidase With Thrombospondin Type 1 Motif 18 (ADAMTS18) in the cochlea and adjacent otic capsule. The white arrowhead indicates ADAMTS18-positive chondrocytes within an expansion front of an ossification center in the otic capsule. The black arrowhead indicates ADAMTS18-positive lateral wall fibrocytes. Asterisk, artefactually folded tissue area; SM, scala media; ST, scala tympani; SV, scala vestibuli. (E–F) Immunofluorescence labeling for Osteoprotegerin (OPG) in the cochlea and adjacent otic capsule after celloidin-removal using either methoxide (E) or PEG 200 (F). Arrowheads, OPG-positive cells near the organ of Corti. SM, scala media; ST, scala tympani; SV, scala vestibuli. (G–H) Immunofluorescence labeling for the 200 kD neurofilament (NF200), α-Tubulin, and DAPI after celloidin-removal using either methoxide (G) or PEG 200 (H) on brain sections. Note the patchy, unspecific staining of the remaining celloidin in (G). GL, granular cell layer; ML, molecular layer; SAS, subarachnoid space; black arrowhead, cranial nerve; white arrowhead, blood vessel. Scale bars: A/E 100 μm; G 200 μm.